Adjuvant therapy for breast cancer.
D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000628:therapy*; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D007223:Infant; D013923:Thromboembolism / Q000139:chemically induced
D000970:Antineoplastic Agents